Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ADAPYAdaptimmune Therapeutics PLC

OTC · CIK 0001621227
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts327

Identity from submissions API

NameAdaptimmune Therapeutics PLC
CIK0001621227
TickersADAPY
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationX0 United Kingdom
Phone44 1235 430000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Adaptimmune Ltd (2014-10-02T00:00:00.000Z → 2015-03-17T00:00:00.000Z)
Business address
60 JUBILEE AVENUE
MILTON PARK
ABINGDON, OXFORDSHIRE
United Kingdom
X0
Mailing address
60 JUBILEE AVENUE
MILTON PARK
ABINGDON, OXFORDSHIRE
United Kingdom
X0

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

808 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-04-22 RW RW 0001104659-26-046473 333-286639 26881596 NE 8614
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001019056-26-000043 005-88833 26636832 34 10735
2025-11-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003290 333-286639 251489163 33 1984
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000554 005-88833 251483062 34 10550
2025-11-13 424B3 e664967_424b3-adaptimmune.htm 0001193805-25-001571 333-233560 251475518 33 141718
2025-11-13 15-12G 15-12G 0001104659-25-110847 001-37368 251475406 34 11119
2025-10-28 S-8 POS S-8 POS 0001104659-25-103166 333-275813 251424838 33 23060
2025-10-28 S-8 POS S-8 POS 0001104659-25-103165 333-233558 251424829 33 23060
2025-10-28 S-8 POS S-8 POS 0001104659-25-103163 333-203929 251424813 33 23060
2025-10-28 POS AM POS AM 0001104659-25-103158 333-286639 251424783 33 20341
2025-10-28 25 FORM 25 0001104659-25-102828 001-37368 251421389 34 15094
2025-10-20 8-K 8-K 3.01,7.01,9.01 0001104659-25-100618 001-37368 251402336 34 194032 1 1
2025-10-08 3 OWNERSHIP DOCUMENT 0001104659-25-098032 3390
2025-09-26 8-K 8-K 3.01 0001104659-25-093882 001-37368 251350960 34 147871 1 1
2025-09-12 8-K 8-K 3.01 0001104659-25-089558 001-37368 251311797 34 151241 1 1
2025-09-08 8-K 8-K 5.02,9.01 0001558370-25-011925 001-37368 251300040 34 321237 1 1
2025-09-03 4 OWNERSHIP DOCUMENT 0001104659-25-087085 6232
2025-09-02 144 xsl144X01/primary_doc.xml 0001104659-25-086007 001-37368 251282998 33 5732
2025-08-29 4 OWNERSHIP DOCUMENT 0001104659-25-085820 6373
2025-08-29 144 xsl144X01/primary_doc.xml 0001104659-25-085819 001-37368 251282364 33 4625
2025-08-29 8-K 8-K 5.02,9.01 0001558370-25-011820 001-37368 251281366 34 262326 1 1
2025-08-19 4 4 0000950170-25-110254 8635
2025-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000670 005-88833 251233431 34 108491
2025-08-19 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000544 005-88833 251233393 34 16773
2025-08-15 8-K 8-K 5.02,9.01 0001558370-25-011616 001-37368 251225083 34 205799 1 1
2025-08-15 144 xsl144X01/primary_doc.xml 0001968582-25-000747 001-37368 251224976 33 8734
2025-08-15 144 xsl144X01/primary_doc.xml 0001968582-25-000746 001-37368 251224956 33 5453
2025-08-14 8-K 8-K 3.01 0001558370-25-011579 001-37368 251219937 34 151299 1 1
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-25-000607 005-88833 251213235 34 11936
2025-08-13 10-Q 10-Q 0001558370-25-011307 001-37368 251209018 34 8182414 1 1
2025-08-13 8-K 8-K 2.02,9.01 0001558370-25-011304 001-37368 251209009 34 523962 1 1
2025-08-07 8-K 8-K 5.02,9.01 0001558370-25-010785 001-37368 251194644 34 267864 1 1
2025-07-31 8-K FORM 8-K 1.02,2.01,9.01 0001104659-25-072753 001-37368 251172580 34 304253 1 1
2025-07-30 4 xslF345X05/ownership.xml 0000935836-25-000476 11988
2025-07-28 8-K FORM 8-K 1.01,2.05,5.02,7.01,9.01 0001104659-25-071009 001-37368 251152952 34 935139 1 1
2025-07-17 8-K 8-K 8.01 0001558370-25-009278 001-37368 251130970 34 149491 1 1
2025-05-29 8-K FORM 8-K 5.07 0001104659-25-054232 001-37368 251003291 34 223596 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-25-000391 005-88833 25949117 34 11699
2025-05-13 10-Q 10-Q 0001558370-25-007571 001-37368 25939966 34 7712403 1 1
2025-05-13 8-K 8-K 2.02,9.01 0001558370-25-007493 001-37368 25937156 34 484433 1 1
2025-05-01 8-K FORM 8-K 3.01 0001104659-25-043522 001-37368 25903313 34 203291 1 1
2025-04-25 ARS ARS 0001104659-25-039416 001-37368 25873955 34 3308150
2025-04-25 DEF 14A DEF 14A 0001104659-25-039042 001-37368 25870047 34 6674588 1 1
2025-04-18 S-3 S-3 0001104659-25-036359 333-286639 25850692 33 860777
2025-04-15 PRE 14A PRE 14A 0001104659-25-034899 001-37368 25837607 34 6696080 1 1
2025-04-14 8-K 8-K 5.02,9.01 0001558370-25-004768 001-37368 25836137 34 211726 1 1
2025-03-24 10-K 10-K 0001558370-25-003544 001-37368 25764736 34 18784798 1 1
2025-03-24 8-K 8-K 1.01,9.01 0001558370-25-003542 001-37368 25764662 34 248362 1 1
2025-03-20 8-K 8-K 2.02,7.01,9.01 0001558370-25-003340 001-37368 25754476 34 249899 1 1
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015746 8981
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015745 8748
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015743 8953
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015742 8929
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015741 8949
2025-02-20 4 OWNERSHIP DOCUMENT 0001104659-25-015739 8922
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000145 005-88833 25623926 34 18107
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001088875-25-000022 005-88833 25612876 34 7489
2025-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001019056-25-000075 005-88833 25610422 34 14627
2025-01-17 4 OWNERSHIP DOCUMENT 0001104659-25-004608 6716
2025-01-17 4 OWNERSHIP DOCUMENT 0001104659-25-004607 6686
2025-01-17 4 OWNERSHIP DOCUMENT 0001104659-25-004606 6718
2025-01-17 4 OWNERSHIP DOCUMENT 0001104659-25-004605 6686
2025-01-17 144 xsl144X01/primary_doc.xml 0001970051-25-000009 001-37368 25538354 33 5749
2025-01-17 144 xsl144X01/primary_doc.xml 0001970051-25-000008 001-37368 25538324 33 5749
2025-01-17 144 xsl144X01/primary_doc.xml 0001970051-25-000007 001-37368 25538291 33 5778
2025-01-17 144 xsl144X01/primary_doc.xml 0001970051-25-000006 001-37368 25538247 33 5757
2025-01-15 4 OWNERSHIP DOCUMENT 0001104659-25-003775 13317
2025-01-15 4 OWNERSHIP DOCUMENT 0001104659-25-003774 6702
2025-01-15 4 OWNERSHIP DOCUMENT 0001104659-25-003771 13437
2025-01-15 4 OWNERSHIP DOCUMENT 0001104659-25-003768 13353
2025-01-15 4 OWNERSHIP DOCUMENT 0001104659-25-003765 13381
2025-01-15 144 xsl144X01/primary_doc.xml 0001970051-25-000005 001-37368 25532899 33 5854
2025-01-15 144 xsl144X01/primary_doc.xml 0001970051-25-000004 001-37368 25532865 33 4470
2025-01-15 144 xsl144X01/primary_doc.xml 0001970051-25-000003 001-37368 25532847 33 5827
2025-01-15 144 xsl144X01/primary_doc.xml 0001970051-25-000002 001-37368 25532824 33 5830
2025-01-15 144 xsl144X01/primary_doc.xml 0001970051-25-000001 001-37368 25532790 33 5811
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000083 005-88833 25517000 34 10307
2024-12-19 8-K 8-K 5.02,8.01,9.01 0001558370-24-016371 001-37368 241560991 34 289375 1 1
2024-12-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-24-006837 005-88833 241529906 34 11188
2024-11-13 10-Q 10-Q 0001558370-24-015532 001-37368 241454571 34 9414065 1 1
2024-11-13 8-K 8-K 2.02,2.05,9.01 0001558370-24-015525 001-37368 241454281 34 545254 1 1
2024-11-13 8-K 8-K 8.01,9.01 0001558370-24-015446 001-37368 241451473 34 195688 1 1
2024-11-13 SC 13G/A ADAPTIMMUNE THERAPEUTICS PLC 0000902664-24-006449 005-88833 241451458 34 63389
2024-11-01 8-K 8-K 3.01 0001558370-24-014148 001-37368 241419865 34 154755 1 1
2024-09-23 8-K 8-K 1.01,9.01 0001558370-24-012960 001-37368 241316413 34 156578 1 1
2024-08-12 10-Q 10-Q 0001558370-24-011798 001-37368 241194741 34 12162139 1 1
2024-08-12 8-K 8-K 2.02,9.01 0001558370-24-011793 001-37368 241194710 34 521894 1 1
2024-08-02 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-085098 001-37368 241168812 34 258699 1 1
2024-07-16 8-K 8-K 5.02,9.01 0001558370-24-009854 001-37368 241119976 34 240191 1 1
2024-07-01 4 4 0000950170-24-079752 33104
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076897 5643
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076895 5702
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076894 5644
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076893 5683
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076891 5646
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076890 5683
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076887 5660
2024-06-18 4 OWNERSHIP DOCUMENT 0001104659-24-072874 6332
2024-06-11 8-K 8-K 5.02,9.01 0001558370-24-009053 001-37368 241035947 34 240347 1 1
2024-05-30 8-K 8-K 1.01,7.01,9.01 0001558370-24-008778 001-37368 241005394 34 205808 1 1
2024-05-15 10-Q 10-Q 0001558370-24-008287 001-37368 24950403 34 6566038 1 1
2024-05-15 8-K 8-K 2.02,9.01 0001558370-24-008210 001-37368 24947176 34 465092 1 1
2024-05-15 8-K 8-K 1.01,2.03,7.01,9.01 0001558370-24-008208 001-37368 24947129 34 198686 1 1
2024-05-14 8-K FORM 8-K 5.07 0001104659-24-060884 001-37368 24941473 34 231483 1 1
2024-04-22 ARS ARS 0001104659-24-050072 001-37368 24862022 34 2771710
2024-04-12 8-K 8-K 1.02,9.01 0001558370-24-004997 001-37368 24840030 34 186946 1 1
2024-04-11 DEF 14A FORM DEF14A 0001104659-24-046093 001-37368 24837155 34 6492275 1 1
2024-04-02 SC 13D/A NEW ENTERPRISE ASSOCIATES 14, L.P. -- ADAPTIMMUNE 13D/A(#2) 0001072613-24-000360 005-88833 24816606 34 435804
2024-04-01 PRE 14A FORM PRE 14A 0001104659-24-041530 001-37368 24805622 34 6509394 1 1
2024-03-26 3 xslF345X02/ownership.xml 0000935836-24-000317 5514
2024-03-26 SC 13G/A adaptimmune13ga.htm 0000935836-24-000316 005-88833 24782133 34 50437
2024-03-18 4 OWNERSHIP DOCUMENT 0001104659-24-035619 8908
2024-03-06 10-K 10-K 0001558370-24-002537 001-37368 24724355 34 17603883 1 1
2024-03-06 8-K 8-K 2.02,9.01 0001558370-24-002536 001-37368 24724348 34 509764 1 1
2024-02-27 8-K 8-K 5.02,9.01 0001558370-24-001756 001-37368 24682090 34 346513 1 1
2024-02-16 8-K 8-K 3.01 0001558370-24-001304 001-37368 24648320 34 151239 1 1
2024-02-14 SC 13G/A SC 13G/A 0001019056-24-000080 005-88833 24640257 34 146458
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023742 005-88833 24638773 34 90879
2024-01-31 8-K 8-K 8.01,9.01 0001558370-24-000672 001-37368 24583862 34 196132 1 1
2024-01-30 SC 13G adaptimmune13g.htm 0000935836-24-000077 005-88833 24579702 34 49720
2024-01-29 SC 13G/A Adaptimmune29122023.txt 0001088875-24-000044 005-88833 24571799 34 11526
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004564 9645
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004563 12983
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004562 12993
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004560 13022
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001773 5582
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004531 8974
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004530 5640
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004528 8949
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004527 8741
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004525 8899
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004524 8742
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004523 8944
2024-01-17 4 OWNERSHIP DOCUMENT 0001104659-24-004520 8920
2024-01-12 4 OWNERSHIP DOCUMENT 0001104659-24-003743 10073
2024-01-12 4 OWNERSHIP DOCUMENT 0001104659-24-003745 10047
2024-01-12 4 OWNERSHIP DOCUMENT 0001104659-24-003742 9988
2024-01-12 4 OWNERSHIP DOCUMENT 0001104659-24-003744 10012
2024-01-04 8-K 8-K 7.01,9.01 0001558370-24-000041 001-37368 24509771 34 181107 1 1
2023-12-06 8-K 8-K 8.01,9.01 0001558370-23-019493 001-37368 231468411 34 189497 1 1
2023-11-30 S-8 FORM S-8 0001104659-23-122434 333-275813 231456064 33 129610
2023-11-14 8-K 8-K 8.01,9.01 0001558370-23-018912 001-37368 231401583 34 159963 1 1
2023-11-08 10-Q 10-Q 0001558370-23-018265 001-37368 231387772 34 8932823 1 1
2023-11-08 SC 13G SC 13G 0001019056-23-000388 005-88833 231386934 34 160554
2023-11-08 8-K 8-K 2.02,9.01 0001558370-23-018123 001-37368 231385985 34 537159 1 1
2023-11-03 8-K 8-K 5.02 0001558370-23-017596 001-37368 231376505 34 242890 1 1
2023-11-01 3 OWNERSHIP DOCUMENT 0001104659-23-113434 4659
2023-10-31 8-K 8-K 7.01,9.01 0001558370-23-017061 001-37368 231362341 34 280071 1 1
2023-09-01 4 OWNERSHIP DOCUMENT 0001104659-23-097853 6234
2023-08-31 8-K 8-K 3.01 0001558370-23-015390 001-37368 231229555 34 153739 1 1
2023-08-10 8-K/A 8-K/A 9.01 0001558370-23-014493 001-37368 231159248 34 1041447 1 1
2023-08-09 10-Q 10-Q 0001558370-23-014250 001-37368 231155109 34 8354980 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001558370-23-014085 001-37368 231153406 34 779014 1 1
2023-08-01 4 OWNERSHIP DOCUMENT 0001104659-23-086416 6266
2023-07-10 4 OWNERSHIP DOCUMENT 0001104659-23-079700 7104
2023-07-10 SC 13G/A ADAPTIMMUNE THERAPEUTICS PLC 0000902664-23-003889 005-88833 231079900 34 65076
2023-07-05 4 OWNERSHIP DOCUMENT 0001104659-23-078201 12837
2023-07-05 4 OWNERSHIP DOCUMENT 0001104659-23-078197 20315
2023-07-05 4 OWNERSHIP DOCUMENT 0001104659-23-078195 22186
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040641 5511
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077673 5599
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077670 5565
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077669 5618
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077668 5580
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077666 5602
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077664 5561
2023-07-03 4 OWNERSHIP DOCUMENT 0001104659-23-077662 5579
2023-06-29 S-8 POS S-8 POS 0001104659-23-076368 333-203929 231058174 33 47575
2023-06-29 S-8 POS S-8 POS 0001104659-23-076358 333-233558 231058104 33 47575
2023-06-29 8-K FORM 8-K 5.02,9.01 0001104659-23-076342 001-37368 231057756 34 702886 1 1
2023-06-27 4 OWNERSHIP DOCUMENT 0001104659-23-075407 6231
2023-06-01 4 OWNERSHIP DOCUMENT 0001104659-23-067118 11385
2023-06-01 3 OWNERSHIP DOCUMENT 0001104659-23-067113 3121
2023-06-01 3 OWNERSHIP DOCUMENT 0001104659-23-067106 3100
2023-06-01 3 OWNERSHIP DOCUMENT 0001104659-23-067105 3082
2023-06-01 8-K FORM 8-K 2.01,5.02,7.01,9.01 0001104659-23-067030 001-37368 23984721 34 898445 1 1
2023-05-30 425 425 0001104659-23-066058 22776
2023-05-30 8-K FORM 8-K 5.07,9.01 0001104659-23-066048 001-37368 23976661 34 220650 1 1
2023-05-22 425 425 0001104659-23-062910 001-37368 23942406 34 169451
2023-05-22 8-K FORM 8-K 8.01 0001104659-23-062908 001-37368 23942400 34 368906 1 1
2023-05-16 8-K FORM 8-K 5.07 0001104659-23-061177 001-37368 23925580 34 219856 1 1
2023-05-12 10-Q 10-Q 0001558370-23-009595 001-37368 23915601 34 5933225 1 1
2023-05-12 8-K 8-K 2.02,9.01 0001558370-23-009504 001-37368 23913177 34 485218 1 1
2023-04-20 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-04-20 16:15:00 9999999995-23-000997 333-271145 23834396 33 1866
2023-04-20 424B3 424B3 0001104659-23-047802 333-271145 23833553 33 4815759
2023-04-18 CORRESP filename1.htm 0001104659-23-046710 7456
2023-04-18 S-4/A S-4/A 0001104659-23-046695 333-271145 23826784 33 6172728
2023-04-13 DEF 14A DEF 14A 0001104659-23-044825 001-37368 23817083 34 10305189 1 1
2023-04-11 8-K 8-K 1.01,7.01,9.01 0001558370-23-005713 001-37368 23812403 34 728218 1 1
2023-04-06 UPLOAD filename1.pdf 0000000000-23-003466 40471
2023-04-05 S-4 S-4 0001104659-23-042202 333-271145 23803137 33 5053745
2023-04-03 PRE 14A PRE 14A 0001104659-23-040544 001-37368 23790676 34 8601462 1 1
2023-03-30 SC 13D/A NEW ENTERPRISE ASSOCIATES 14, L.P. -- ADAPTIMMUNE 13D/A(#1) 0001072613-23-000276 005-88833 23781736 34 548446
2023-03-10 8-K 8-K 7.01,9.01 0001558370-23-003489 001-37368 23724447 34 154259 1 1
2023-03-09 425 425 0001104659-23-030597 52427
2023-03-09 425 425 0001104659-23-030593 166135
2023-03-06 10-K 10-K 0001558370-23-002907 001-37368 23708959 34 15776199 1 1
2023-03-06 8-K 8-K 1.02,2.02,5.02,9.01 0001558370-23-002829 001-37368 23707495 34 630341 1 1
2023-03-06 425 425 0001104659-23-028735 001-37368 23707491 34 22685111
2023-03-06 8-K FORM 8-K 1.01,7.01,9.01 0001104659-23-028734 001-37368 23707490 34 23138081 1 1
2023-02-16 8-K 8-K 5.02,7.01,9.01 0001558370-23-001414 001-37368 23637204 34 410553 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021575 005-88833 23628985 34 105975
2023-02-13 SC 13G/A SEC SCHEDULE 13G 0001422849-23-000022 005-88833 23617284 34 18343
2023-01-31 4 OWNERSHIP DOCUMENT 0001104659-23-008858 6550
2023-01-31 8-K 8-K 1.02,9.01 0001558370-23-000722 001-37368 23572727 34 154322 1 1
2023-01-18 SC 13G/A Adaptimmune30122022.txt 0001088875-23-000006 005-88833 23532889 34 11445
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004382 6566
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004381 6600
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004380 6563
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004379 6539
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004377 11297
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004376 11268
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004374 11059
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004373 11226
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004372 11075
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004371 11264
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004370 11245
2023-01-17 4 OWNERSHIP DOCUMENT 0001104659-23-004369 8809
2023-01-12 4 OWNERSHIP DOCUMENT 0001104659-23-003539 9928
2023-01-12 4 OWNERSHIP DOCUMENT 0001104659-23-003538 9900
2023-01-12 4 OWNERSHIP DOCUMENT 0001104659-23-003535 9958
2023-01-12 4 OWNERSHIP DOCUMENT 0001104659-23-003534 9871
2023-01-04 4 OWNERSHIP DOCUMENT 0001104659-23-001092 6555
2023-01-04 4 OWNERSHIP DOCUMENT 0001104659-23-001090 6528
2023-01-04 4 OWNERSHIP DOCUMENT 0001104659-23-001089 6554
2023-01-04 4 OWNERSHIP DOCUMENT 0001104659-23-001088 6494
2022-12-20 8-K 8-K 1.01,9.01 0001558370-22-018828 001-37368 221474765 34 227533 1 1
2022-12-02 SC 13G/A Adaptimmune30112022.txt 0001088875-22-000130 005-88833 221440281 34 11450
2022-11-08 10-Q 10-Q 0001558370-22-016869 001-37368 221369054 34 6204527 1 1
2022-11-08 8-K 8-K 2.02,9.01 0001558370-22-016748 001-37368 221367283 34 510990 1 1
2022-11-08 8-K 8-K 7.01,9.01 0001558370-22-016746 001-37368 221367276 34 203119 1 1
2022-10-25 8-K 8-K 1.02,9.01 0001558370-22-015279 001-37368 221327229 34 186785 1 1
2022-09-09 8-K 8-K 7.01,9.01 0001558370-22-014297 001-37368 221235039 34 462318 1 1
2022-09-01 4 OWNERSHIP DOCUMENT 0001104659-22-097135 6204
2022-08-04 10-Q 10-Q 0001558370-22-012182 001-37368 221136518 34 6329554 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001558370-22-012058 001-37368 221134723 34 505859 1 1
2022-08-01 4 OWNERSHIP DOCUMENT 0001104659-22-084894 6574
2022-08-01 4 OWNERSHIP DOCUMENT 0001104659-22-084893 6537
2022-07-05 4 OWNERSHIP DOCUMENT 0001104659-22-077470 6568
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040313 5479
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076901 5591
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076900 5564
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076898 5530
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076897 5598
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076896 5546
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076895 5596
2022-07-01 4 OWNERSHIP DOCUMENT 0001104659-22-076894 5527
2022-06-27 4 OWNERSHIP DOCUMENT 0001104659-22-074926 6198
2022-06-15 8-K 8-K 1.01,9.01 0001558370-22-010042 001-37368 221017874 34 731894 1 1
2022-05-25 8-K FORM 8-K 5.07 0001104659-22-064428 001-37368 22958856 34 217547 1 1
2022-05-23 4 OWNERSHIP DOCUMENT 0001104659-22-064008 5773
2022-05-09 SC 13G SC 13G 0001104659-22-057601 005-88833 22905866 34 101492
2022-05-09 10-Q 10-Q 0001558370-22-007810 001-37368 22904896 34 5240200 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001558370-22-007708 001-37368 22903264 34 453797 1 1
2022-05-04 4 OWNERSHIP DOCUMENT 0001104659-22-056007 8528
2022-05-04 3 OWNERSHIP DOCUMENT 0001104659-22-056004 3141
2022-05-04 8-K 8-K 5.02,9.01 0001558370-22-006948 001-37368 22889907 34 507580 1 1
2022-04-28 424B5 424B5 0001104659-22-051654 333-264208 22862342 33 306475
2022-04-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-22 16:00:00 9999999995-22-001066 333-264208 22847181 33 1866
2022-04-21 CORRESP filename1.htm 0001104659-22-048444 7723
2022-04-21 S-3/A S-3/A 0001104659-22-048378 333-264208 22841452 33 739478
2022-04-21 DEF 14A DEF 14A 0001104659-22-048084 001-37368 22839696 34 4788309
2022-04-15 UPLOAD filename1.pdf 0000000000-22-004106 40436
2022-04-11 PRE 14A PRE 14A 0001104659-22-044463 001-37368 22818504 34 3016727
2022-04-08 S-3 S-3 0001104659-22-044275 333-264208 22817487 33 1191823
2022-03-14 8-K 8-K 2.02,9.01 0001558370-22-003492 001-37368 22735126 34 527307 1 1
2022-03-14 10-K 10-K 0001558370-22-003489 001-37368 22735066 34 14263914 1 1
2022-03-01 NT 10-K NT 10-K 0001104659-22-028713 001-37368 22698600 34 20864
2022-01-31 4 OWNERSHIP DOCUMENT 0001104659-22-009932 11241
2022-01-31 3 OWNERSHIP DOCUMENT 0001104659-22-009928 3126
2022-01-26 8-K FORM 8-K 5.02,9.01 0001104659-22-007650 001-37368 22555734 34 352604 1 1
2022-01-18 4 OWNERSHIP DOCUMENT 0001104659-22-005056 6607
2022-01-18 4 OWNERSHIP DOCUMENT 0001104659-22-005055 6571
2022-01-18 4 OWNERSHIP DOCUMENT 0001104659-22-005054 6567
2022-01-18 4 OWNERSHIP DOCUMENT 0001104659-22-005053 6538
2022-01-18 SC 13G/A Adaptimmune31122021.txt 0001088875-22-000014 005-88833 22533610 34 11445
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004157 8828
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004156 8778
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004154 8623
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004153 9930
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004152 9902
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004151 8829
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004150 9957
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004149 9870
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004148 8858
2022-01-13 4 OWNERSHIP DOCUMENT 0001104659-22-004147 8801
2022-01-05 4 OWNERSHIP DOCUMENT 0001104659-22-001671 6556
2022-01-05 4 OWNERSHIP DOCUMENT 0001104659-22-001670 6528
2022-01-05 4 OWNERSHIP DOCUMENT 0001104659-22-001669 6554
2022-01-05 4 OWNERSHIP DOCUMENT 0001104659-22-001668 6494
2021-11-12 8-K 8-K 7.01,9.01 0001558370-21-015611 001-37368 211399258 34 212789 1 1
2021-11-04 10-Q 10-Q 0001558370-21-014594 001-37368 211380062 34 7044225 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001558370-21-014450 001-37368 211378045 34 523706 1 1
2021-09-13 8-K 8-K 8.01,9.01 0001558370-21-012408 001-37368 211248598 34 222273 1 1
2021-09-07 8-K 8-K 1.01,7.01,8.01,9.01 0001558370-21-012236 001-37368 211238243 34 201365 1 1
2021-09-01 4 OWNERSHIP DOCUMENT 0001104659-21-112179 6540
2021-08-20 8-K 8-K 1.01,9.01 0001558370-21-011988 001-37368 211194242 34 913364 1 1
2021-08-13 8-K 8-K 1.01,9.01 0001558370-21-011688 001-37368 211172717 34 1285169 1 1
2021-08-09 10-Q 10-Q 0001558370-21-010980 001-37368 211156766 34 4788862 1 1
2021-08-09 8-K 8-K 2.02,9.01 0001558370-21-010969 001-37368 211156518 34 503293 1 1
2021-08-02 4 OWNERSHIP DOCUMENT 0001104659-21-098959 6571
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-089050 6532
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-089048 6498
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088974 5589
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088972 5562
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088971 5526
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088969 5527
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088967 5543
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088965 5521
2021-07-02 4 FORM 4 SUBMISSION 0001209191-21-045059 5476
2021-07-02 4 OWNERSHIP DOCUMENT 0001104659-21-088960 5593
2021-06-28 4 OWNERSHIP DOCUMENT 0001104659-21-086385 6198
2021-06-03 4 OWNERSHIP DOCUMENT 0001104659-21-076401 7447
2021-05-19 8-K 8-K 7.01,9.01 0001558370-21-007554 001-37368 21941123 34 198117 1 1
2021-05-14 8-K FORM 8-K 5.07 0001104659-21-066437 001-37368 21922072 34 228226 1 1
2021-05-06 10-Q 10-Q 0001558370-21-006230 001-37368 21898003 34 3992032 1 1
2021-05-06 8-K 8-K 2.02,9.01 0001558370-21-006075 001-37368 21895833 34 468410 1 1
2021-04-08 DEF 14A DEF 14A 0001104659-21-047833 001-37368 21813809 34 4498297
2021-03-29 PRE 14A PRE 14A 0001104659-21-042777 001-37368 21779509 34 2656259
2021-03-03 4 OWNERSHIP DOCUMENT 0001104659-21-031733 6008
2021-02-25 10-K 10-K 0001558370-21-001827 001-37368 21680594 34 14073085 1 1
2021-02-25 8-K 8-K 2.02,9.01 0001558370-21-001720 001-37368 21676435 34 550379 1 1
2021-02-16 SC 13G SCHEDULE 13G 0001104659-21-023944 005-88833 21638306 34 89734
2021-02-16 SC 13G SEC SCHEDULE 13G 0001422849-21-000015 005-88833 21634535 34 18425
2021-02-16 SC 13G/A ADAPTIMMUNE THERAPEUTICS PLC 0000902664-21-001372 005-88833 21633767 34 64436
2021-01-28 SC 13G Adaptimmune31122020.txt 0001088875-21-000050 005-88833 21561978 34 11452
2021-01-19 4 OWNERSHIP DOCUMENT 0001104659-21-005546 6510
2021-01-19 4 OWNERSHIP DOCUMENT 0001104659-21-005545 6515
2021-01-19 4 OWNERSHIP DOCUMENT 0001104659-21-005544 6552
2021-01-12 4 OWNERSHIP DOCUMENT 0001104659-21-003594 6545
2021-01-12 4 OWNERSHIP DOCUMENT 0001104659-21-003592 6515
2021-01-12 4 OWNERSHIP DOCUMENT 0001104659-21-003591 6544
2021-01-12 4 OWNERSHIP DOCUMENT 0001104659-21-003590 6551
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003134 8564
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003133 8761
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003132 8798
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003131 8747
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003130 8761
2021-01-11 4 OWNERSHIP DOCUMENT 0001104659-21-003129 8791
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-001178 6514
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-001177 6544
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-001176 6543
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-001175 6550
2020-12-16 4 OWNERSHIP DOCUMENT 0001104659-20-136481 5716
2020-12-16 8-K FORM 8-K 5.02,9.01 0001104659-20-136370 001-37368 201393129 34 315320 1 1
2020-12-15 4 OWNERSHIP DOCUMENT 0001104659-20-135891 6190
2020-11-20 8-K 8-K 7.01,9.01 0001558370-20-014003 001-37368 201330477 34 210736 1 1
2020-11-19 8-K 8-K 7.01,9.01 0001558370-20-013984 001-37368 201327259 34 189333 1 1
2020-11-09 8-K FORM 8-K 7.01,9.01 0001104659-20-123143 001-37368 201298693 34 238314 1 1
2020-11-05 10-Q 10-Q 0001558370-20-012867 001-37368 201290716 34 5304991 1 1
2020-11-05 8-K FORM 8-K 2.02,9.01 0001104659-20-121583 001-37368 201288719 34 349190 1 1
2020-11-04 CT ORDER filename1.pdf 20201104,20201104 9999999997-20-005282 001-37368 201285414 34 11033
2020-10-15 8-K FORM 8-K 7.01,9.01 0001104659-20-115322 001-37368 201241868 34 235127 1 1
2020-09-02 4 4 0001104659-20-101976 6437
2020-08-28 8-K FORM 8-K 7.01,9.01 0001104659-20-099887 001-37368 201145683 34 235801 1 1
2020-08-10 S-3ASR S-3ASR 0001104659-20-092818 333-243743 201090169 33 1804188
2020-08-06 10-Q 10-Q 0001558370-20-009555 001-37368 201080521 34 5229161 1 1
2020-08-06 8-K FORM 8-K 2.02,9.01 0001104659-20-091131 001-37368 201079852 34 350734 1 1
2020-08-04 4 4 0001104659-20-090470 6585
2020-08-04 4 4 0001104659-20-090469 5792
2020-08-04 4 4 0001104659-20-090468 6377
2020-07-01 4 FORM 4 SUBMISSION 0001209191-20-039805 5476
2020-07-01 4 4 0001104659-20-079793 5393
2020-07-01 4 4 0001104659-20-079789 5437
2020-07-01 4 4 0001104659-20-079788 5408
2020-07-01 4 4 0001104659-20-079787 5400
2020-07-01 4 4 0001104659-20-079786 5423
2020-07-01 4 4 0001104659-20-079783 5401
2020-07-01 4 4 0001104659-20-079782 5467
2020-06-30 4 4 0001104659-20-079248 5328
2020-06-11 4 4 0001104659-20-072556 7309
2020-06-02 4 4 0001104659-20-069142 5545
2020-06-02 424B5 424B5 0001047469-20-003304 333-233557 20937945 33 516161
2020-06-02 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-069003 001-37368 20937768 34 659848 1 1
2020-06-01 424B5 424B5 0001047469-20-003280 333-233557 20930822 33 519122
2020-05-29 8-K FORM 8-K 7.01,9.01 0001104659-20-067350 001-37368 20924043 34 262533 1 1
2020-05-29 8-K FORM-8K 5.07 0001104659-20-067340 001-37368 20924023 34 226387 1 1
2020-05-28 10-Q/A FORM 10-Q/A 0001104659-20-067101 001-37368 20921660 34 235475 1 1
2020-05-14 10-Q 10-Q 0001558370-20-006569 001-37368 20876158 34 4650490 1 1
2020-05-14 8-K FORM 8-K 2.02,9.01 0001104659-20-061166 001-37368 20875301 34 346496 1 1
2020-05-12 8-K FORM 8-K 7.01,9.01 0001104659-20-059925 001-37368 20867178 34 229897 1 1
2020-04-29 8-K FORM 8-K 8.01,9.01 0001104659-20-052846 001-37368 20827492 34 243027 1 1
2020-04-28 8-K FORM 8-K 8.01,9.01 0001104659-20-051986 001-37368 20822422 34 241176 1 1
2020-04-20 DEF 14A DEF 14A 0001104659-20-048476 001-37368 20801280 34 4899227
2020-04-08 8-K FORM 8-K 5.02 0001104659-20-044489 001-37368 20781132 34 198334 1 1
2020-04-08 PRE 14A PRE 14A 0001104659-20-044488 001-37368 20781115 34 1202093
2020-04-01 4 4 0001104659-20-042013 5398
2020-04-01 4 4 0001104659-20-042012 8443
2020-04-01 3 3 0001104659-20-042011 3011
2020-02-27 10-K 10-K 0001558370-20-001571 001-37368 20659713 34 15702979 1 1
2020-02-27 8-K FORM 8-K 2.02,9.01 0001104659-20-025722 001-37368 20658498 34 326181 1 1
2020-02-18 8-K FORM 8-K 5.02,8.01,9.01 0001104659-20-022267 001-37368 20623563 34 553658 1 1
2020-02-14 SC 13G/A ADAPTIMMUNE THERAPEUTICS PLC 0000902664-20-001127 005-88833 20615286 34 60896
2020-02-14 SC 13G/A SC 13G/A 0001422849-20-000007 005-88833 20613300 34 9298
2020-02-07 8-K FORM 8-K 8.01,9.01 0001104659-20-012543 001-37368 20587741 34 250245 1 1
2020-01-28 4 FORM 4 SUBMISSION 0001209191-20-005173 8013
2020-01-28 4 FORM 4 SUBMISSION 0001209191-20-005172 7921
2020-01-28 4 FORM 4 SUBMISSION 0001209191-20-005170 8015
2020-01-28 4 FORM 4 SUBMISSION 0001209191-20-005168 8053
2020-01-28 4 FORM 4 SUBMISSION 0001209191-20-005167 6135

Latest XBRL company facts

One latest value per concept from companyfacts (327 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 1.59B 2025-08-11 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
dei EntityPublicFloat Entity Public Float USD 230.88M 2024-06-30 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.42M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 326,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 1.45M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 9.31M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 24.53M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 75.03M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -10.61M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.11B 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AdjustmentForAmortization Amortization USD 355,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.36M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 979,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001558370-20-006569
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.99M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 20.63M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001558370-22-003489
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 411,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 261.88M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap Assets Assets USD 130.63M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AssetsCurrent Assets, Current USD 78.11M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.30M 2017-06-30 2017 Q2 10-Q 2017-08-03 0001104659-17-049218
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 9.19M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007571
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 9.19M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007571
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD -646,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses USD 646,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions security 54 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year security 0 2019-03-31 2019 Q1 10-Q 2019-05-06 0001558370-19-004059
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 22.05M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 45.26M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 26.06M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -53.82M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001104659-16-156035
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 27.78M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -65.43M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share GBP/shares 0.001 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 2.11B 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1.59B 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1.59B 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CommonStockValue Common Stock, Value, Issued USD 2.16M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -86.63M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 112.12M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD 10.40M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress USD 5.03M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.70M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 101.42M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 5.81M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 7.42M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001558370-22-003489
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 3.38M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CostsAndExpenses Costs and Expenses USD 96.98M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 8.64M 2017-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD 8.64M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 3.51M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 26,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3.58M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 67,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 50.00M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent Debt Securities, Available-for-sale, Allowance for Credit Loss, Current USD 0 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent USD 0 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 833,000 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002907
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions security 5 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007810
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 1.54M 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007810
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 930,000 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002907
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions security 19 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002907
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD -2.47M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001827
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 1.48M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015532
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015532
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 1 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015532
us-gaap DebtWeightedAverageInterestRate Debt, Weighted Average Interest Rate pure 0.072 2019-06-30 2019 Q2 10-Q 2019-08-01 0001558370-19-006758
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.61M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 38.73M 2017-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 95.98M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007571
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 115,000 2015-06-30 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 348,000 2016-12-31 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 313.10M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-06 0001558370-24-002537
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.61M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 183,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 15.77M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 144,000 2016-12-31 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 2.73M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 309.49M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD 3,000 2017-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.96M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 637,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.01M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 46,000 2014-06-30 8-K 2016-07-08 0001104659-16-131771
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 3.08M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap Depreciation Depreciation USD 4.62M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 2,000 2015-12-31 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.05 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.13 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014594
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.05 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 3.33M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -4.08M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001104659-16-156035
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -34,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.59M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8.49M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 617,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 8,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 26.00M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 21.00M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 6.14M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 585,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 652,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 24,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 24,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 467,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 542,000 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 246,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 247,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 416,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 552,000 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 9.45M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 3.88M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 1.37 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 907,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009555
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 888,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -194,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-03 0001104659-17-049218
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 38.81M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001558370-24-011798
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 10.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -76.74M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments GBP 24.20M 2024-01-19 2023 FY 10-K 2024-03-06 0001558370-24-002537
us-gaap IncomeTaxesPaid Income Taxes Paid USD 630,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002907
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 48.54M 2022-09-30 2022 Q3 10-Q 2022-11-08 0001558370-22-016869
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.19M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 21.48M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-06 0001558370-23-002907
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD -11.41M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 3.57M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009555
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -5.81M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.04M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -562,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -615,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009555
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 4.67M 2015-07-01 2015-12-31 8-K 2016-07-08 0001104659-16-131771
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 4.67M 2015-07-01 2015-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 26.62M 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 3.81M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InterestExpense Interest Expense USD 14,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-02 0001104659-17-065442
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2.84M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InterestIncomeDebtSecuritiesAvailableForSaleOperating Interest Income, Debt Securities, Available-for-sale, Operating USD 4.82M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015532
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 240,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001104659-17-031428
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2.09M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 490,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InventoryNet Inventory, Net USD 11.41M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 10.76M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 160,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 1.41M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 2.52M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.02M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012867
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD -1.27M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 1.14M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 3.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap LeaseCost Lease, Cost USD 3.32M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 29.84M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.75M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007571
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.77M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 4.37M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001558370-25-007571
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.50M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 4.44M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.39M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.79M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6.84M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap Liabilities Liabilities USD 201.59M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 130.63M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.51M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap LongTermDebt Long-term Debt USD 54.28M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 17.91M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 23.60M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 12.77M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 25.68M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap MarketableSecurities Marketable Securities USD 60.47M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -23.67M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 61.40M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001104659-17-031428
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 59.64M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -22.64M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001104659-17-031428
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -101.37M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 73.20M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -77.92M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -77.92M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -77.92M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap NoncurrentAssets Long-Lived Assets USD 51.22M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.35M 2015-07-01 2015-12-31 8-K 2016-07-08 0001104659-16-131771
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingExpenses Operating Expenses USD 19.74M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001104659-16-120341
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -76.02M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.29M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3.40M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001827
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 23.00M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.51M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 18.49M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeasePayments Operating Lease, Payments USD 6.98M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 18.75M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 31.96M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.68M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 3.31M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 3.77M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 3.73M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 3.69M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 13.77M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 31.96M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 3.68M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 3.31M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 3.77M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 3.73M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 3.69M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 13.77M 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 479,000 2017-09-30 2017 Q3 10-Q 2017-11-02 0001104659-17-065442
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.102 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 4.03M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 5.00M 2019-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap OtherAssetsCurrent Other Assets, Current USD 3.52M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 94,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -79.05M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 70.36M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -6.20M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Investment Transferred from Available-for-sale to Equity Method, after Tax USD 13,000 2019-04-01 2019-06-30 2019 Q3 10-Q 2019-11-06 0001558370-19-010099
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD 13,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-06 0001558370-20-009555
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 198,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax USD 1.31M 2018-04-01 2018-06-30 2019 Q3 10-Q 2019-11-06 0001558370-19-010099
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -17,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.99M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 4.49M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherNoncashExpense Other Noncash Expense USD 237,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 984,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 56,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap OtherPreferredStockDividendsAndAdjustments Other Preferred Stock Dividends and Adjustments USD 14.73M 2014-07-01 2015-06-30 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD -913,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001558370-23-018265
us-gaap PaymentsForRent Payments for Rent USD 1.74M 2021-08-13 2021 FY 10-K 2022-03-14 0001558370-22-003489
us-gaap PaymentsForRestructuring Payments for Restructuring USD 6.02M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 588,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 15.99M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-12 0001104659-16-120341
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 16.09M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.28M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 31.33M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.23M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 1.52M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ProceedsFromInterestReceived Proceeds from Interest Received USD 5.31M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 175.99M 2014-07-01 2015-06-30 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.77M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 24.50M 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 98.87M 2014-07-01 2015-06-30 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 14.65M 2024-01-01 2024-03-04 2023 FY 10-K 2024-03-06 0001558370-24-002537
us-gaap ProceedsFromRepaymentsOfBankOverdrafts Proceeds from (Repayments of) Bank Overdrafts USD -1.29M 2013-07-01 2014-06-30 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 44.06M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 76.95M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 4.94M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromSaleOfOtherAssetsInvestingActivities Proceeds from Sale of Other Assets, Investing Activities USD 62,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 550,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 10,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -77.92M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 83.20M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 28.15M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap PurchaseObligation Purchase Obligation USD 5.00M 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001827
us-gaap RecordedUnconditionalPurchaseObligation Recorded Unconditional Purchase Obligation USD 5.00M 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001827
us-gaap RepaymentsOfDebt Repayments of Debt USD 25.45M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 52,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 51.84M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestrictedCash Restricted Cash USD 1.72M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 2.07M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.72M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 5.91M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 8.39M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 240,000 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 2.23M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.33 2024-11-13 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringCharges Restructuring Charges USD 2.18M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringReserve Restructuring Reserve USD 2.35M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 57,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD 230,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.17B 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 20.96M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 121.31M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap Revenues Revenues USD 20.96M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 37.83M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 41.77M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.99M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 361,222 2016-08-01 2016-08-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.6 2014-07-01 2015-06-30 2017 FY 10-K 2018-03-15 0001104659-18-017694
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.73 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.69 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.017 2013-07-01 2014-06-30 2016 FY 10-K 2017-03-13 0001104659-17-016024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.009 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.002 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 15.21M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 47.68M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price GBP 0.55 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.28M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 2.82M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 24.71M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.07 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value GBP 131,000 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 87.56M 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price GBP 0.6 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price GBP 0.42 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price GBP 0.8 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price GBP 0.63 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001558370-19-001209
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price GBP/shares 0.5 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 129.11M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 253.39M 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price GBP/shares 0.31 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 32,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -70.96M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 147.68M 2019-09-30 2019 Q3 10-Q 2019-11-06 0001558370-19-010099
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 211.63M 2017-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001571
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 8.98M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 60.76M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 188,000 2023-01-01 2023-03-31 2024 Q3 10-Q 2024-11-13 0001558370-24-015532
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 1.80M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001558370-23-009595
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap UndistributedEarningsOfDomesticSubsidiaries Undistributed Earnings of Domestic Subsidiaries USD 0 2015-12-31 8-K 2016-07-08 0001104659-16-131771
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 14.57M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001558370-25-003544
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 1.30M 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.56B 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 934.83M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001558370-22-003489
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.56B 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001558370-25-011307

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →